Personalized Integrative Oncology: Targeted Approaches for Optimal Outcomes

个性化综合肿瘤学：实现最佳结果的针对性方法

• 批准号: 8838465
• 负责人: Lorenzo Cohen
• 金额: $ 0.8万
• 依托单位: UNIVERSITY OF TX MD ANDERSON CAN CTR
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-09-01 至 2015-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8838465
• 关键词: Academy; Address; Advocate; Affect; American; Area; Basic Science; British Columbia; Canada; Case Study; Clinical; Clinical Research; Clinical Sciences; Clinical Trials; Collaborations; Communities; Data; Development; Educational workshop; Epigenetic Process; Fostering; Future; Growth; Guidelines; Health Professional; Healthcare; Institution; Integrative Medicine; International; Joints; Knowledge; Learning; Life Style; Malignant Neoplasms; Oncologist; Oral; Outcome; Palliative Medicine; Patient Care; Patient advocacy; Patients; Prevention; Recording of previous events; Recovery; Research; Research Methodology; Research Personnel; Role; Sleep Disorders; Societies; Stream; Stress; Targeted Research; Technology; Texas; Therapeutic; Time; Training; United States; Universities; University of Texas M D Anderson Cancer Center; Work; base; career; clinical practice; dissemination research; evidence base; experience; hospice environment; improved; innovation; knowledge translation; lectures; malignant breast neoplasm; meetings; member; mindfulness; multidisciplinary; next generation; oncology; posters; programs; public health relevance; stem; symposium; symptom management; tumor

DESCRIPTION (provided by applicant): The Society for Integrative Oncology (SIO) 11th International Conference, entitled "Personalized Integrative Oncology: Targeted Approach For Optimal Outcomes", aims to critically examine recent advances in research that have the potential to improve the practice of integrative oncology as a contemporary health care option. This conference will focus on disseminating important findings from integrative oncology research that are taking a targeted approach including both basic and clinical science, to ultimately improve the outcome of patient care. The overarching aim of the SIO 2014 conference is to highlight the unique trajectory of targeted integrative oncology research, knowledge development, and its implication in integrative oncology. The 2 and 1/2-day meeting is being held in Houston and is co-hosted by the University of Texas MD Anderson Cancer Center. The 2014 SIO conference program contains three keynote lectures that will directly address current research in targeted integrated oncology including the: 1) The role of personalized integrative oncology in the prevention, treatment and recovery from cancer; 2) The impact of stress on patients with cancer; and 3) The intersection of sleep disorders and cancer. In addition to keynote lectures, the conference will include: four moderated plenary panels are planned covering: 1) personalized integrative oncology; 2) the role of lifestyle and epigenetics in the context of cancer; 3) a joint session with AAHPM to tackle targeted symptom management; and 4) breast cancer guidelines. The conference will also have two multidisciplinary integrative tumor boards; two preconference workshops to focus on clinical research and clinical practice relevant to innovated integrative oncology; four didactic and experiential workshops; a public lecture on mindfulness practices in integrative oncology; and patient advocacy and trainee streams. Presentations of original research, in various topics related to targeted integrated oncology, including clinical trials, basic science, and research methodology, will be solicited from members of the national and international research communities for 45 oral and up to 80 poster presentations. The conference aims are to: 1) Create an international venue in which researchers, clinicians and patient advocates can discuss the current evidence regarding targeted integrative oncology research and practices and enhance their understanding the advantage and challenge of this particular field; 2) Foster dialogue, collaboration and networking among researchers, health professionals, and patient advocates, facilitating future research and knowledge using targeted strategies in the field of integrative oncology; and 3) Assist in the training of trainees, early career investigators and patient advocates in creating, interpreting an disseminating evidence-based integrative oncology research. Ultimately, it is our hope that the renewed knowledge and clinical practice on targeted integrative oncology obtained from this conference will improve the outcome of patient care by integrative oncologist and practitioners.

描述(由申请者提供)：综合肿瘤学学会(SIO)第11届国际会议题为“个性化综合肿瘤学：达到最佳结果的有针对性的方法”，旨在批判性地检查最新的研究进展，这些进展有可能改善综合肿瘤学作为当代保健选择的实践。本次会议将重点传播综合肿瘤学研究的重要发现，这些研究正在采取有针对性的方法，包括基础和临床科学，以最终改善患者护理的结果。SIO 2014大会的总体目标是突出有针对性的综合肿瘤学研究、知识开发及其在综合肿瘤学中的意义的独特轨迹。这次为期两天半的会议在休斯顿举行，由德克萨斯大学MD安德森癌症中心联合主办。2014年SIO会议计划包含三个主题演讲，将直接讨论目标整合肿瘤学的当前研究，包括：1)个性化整合肿瘤学在癌症预防、治疗和康复中的作用；2)压力对癌症患者的影响；以及3)睡眠障碍和癌症的交集。除了主旨演讲外，会议还将包括：计划中的四个主持全体小组讨论：1)个性化的综合肿瘤学；2)生活方式和表观遗传学在 癌症的背景；3)与AAHPM的联合会议，以解决有针对性的症状管理；以及4)乳腺癌指南。会议还将有两个多学科综合肿瘤委员会；两个会议前研讨会，重点关注与创新的综合肿瘤学相关的临床研究和临床实践；四个授课和体验式研讨会；关于综合肿瘤学中正念实践的公开讲座；以及患者倡导和实习生流。与有针对性的综合肿瘤学相关的各种主题的原创研究报告，包括临床试验、基础科学和研究方法，将征求国内和国际研究界成员的45次口头报告和最多80份海报报告。会议的目的是：1)创建一个国际论坛，让研究人员、临床医生和患者权益倡导者可以讨论关于有针对性的综合肿瘤学研究和实践的当前证据，并增进他们对这一特定领域的优势和挑战的了解；2)促进研究人员、卫生专业人员和患者权益倡导者之间的对话、合作和网络，促进未来的研究和知识，使用综合肿瘤学领域的有针对性的战略；以及3)协助培训学员、早期职业研究人员和患者权益倡导者，以创建、解释和传播基于证据的综合肿瘤学研究。最终，我们希望从这次会议上获得的关于靶向综合肿瘤学的新知识和临床实践将改善综合肿瘤学家和从业者对患者的护理结果。

项目成果

Personalized integrative oncology: targeted approaches for optimal outcomes: the 11th International Conference of the Society for Integrative Oncology.

个性化综合肿瘤学：最佳结果的针对性方法：第 11 届综合肿瘤学学会国际会议。

• DOI: 10.1177/1534735414563603
• 发表时间: 2015
• 期刊: Integrative cancer therapies
• 影响因子: 2.9
• 作者: Lee,RichardT;Yang,Peiying;Greenlee,Heather;Bauer-Wu,Susan;Balneaves,LyndaG;Zick,Suzanna
• 通讯作者: Zick,Suzanna